Oruka Therapeutics, Inc. Lessee, Operating Lease, Discount Rate
Oruka Therapeutics, Inc. (ORKA) had Lessee, Operating Lease, Discount Rate of 17.95% as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2025-05-14
- 2025-03-31: Lessee, Operating Lease, Discount Rate 17.95%.
- 2024-12-31: Lessee, Operating Lease, Discount Rate 17.95%.
- 2024-09-30: Lessee, Operating Lease, Discount Rate 17.95%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2025-03-31 | 17.95% 10-Q · filed 2025-05-14 |
| 2024-12-31 | 17.95% 10-K · filed 2025-03-06 |
| 2024-09-30 | 17.95% 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |